Inhibitory Activity of Ethanol Extract from Artemisia argyi on a Clinical Isolate of Staphylococcus aureus

Fan Zhang^1*, Fan Wang¹, Liang Xiao¹, Guoping Sun^2*

¹Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
²Department of Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

DOI: 10.4236/cm.2014.54029                

Abstract

As a traditional herbal medicine for the treatment of many disorders, Artemisia argyi has shown many valuable bioactivities, but little is known about its effect on Staphylococcus aureus. In this study, the growth, the biofilm formation and the pathogenicity of S. aureus cultivated with or without ethanol extract of A. argyi were tested using microtitre plate assay, Confocal Laser Scanning Microscope (CLSM) system and mice infection assay. Results showed that the growth and the biofilm formation of S. aureus in the test group with ethanol extract of A. argyi were significantly lower than those of the control group without ethanol extract of A. argyi. With CLSM system we could observe that the biofilm structure of the test group had looser and less biomass compared with the control group. After infection of S. aureus, the survival of mice in test group that were given 0.2 mL 100 mg/mL ethanol extracts of A. argyi was higher than the control group. Histopathological analyses showed that the tissue damage of mice in test group was less than that in control group. These results suggested that ethanol extract of A. argyi had inhibitory effect on S. aureus and could protect mice from death induced by S. aureus infection.

Keywords

Artemisia argyi, Staphylococcus aureus, Biofilm Formation, Pathogenicity

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Bao, X., Yuan, H., Wang, C., Liu, J. and Lan, M. (2012) Antitumor and Immunomodulatory Activities of a Polysaccharide from Artemisia argyi. Carbohydrate Polymers, 98, 1236-1243. http://dx.doi.org/10.1016/j.carbpol.2013.07.018
[2]	Adams, M., Efferth, T. and Bauer, R. (2006) Activity-Guided Isolation of Scopoletin and Isoscopoletin, the Inhibitory Active Principles towards CCRF-CEM Leukaemia Cells and Multi-Drug Resistant CEM/ADR5000 Cells, from Artemisia argyi. Planta Medica, 72, 862-864. http://dx.doi.org/10.1055/s-2006-947165
[3]	Khan, M., Yu, B., Rasul, A., Al Shawi, A., Yi, F., Yang, H. and Ma, T. (2012) Jaceosidin Induces Apoptosis in U87 Glioblastoma Cells through G2/M Phase Arrest. Evidence-Based Complementary and Alternative Medicine, 2012, 112.
[4]	Yoon, K.D., Chin, Y.W., Yang, M.H. and Kim, J. (2011) Separation of Anti-Ulcer Flavonoids from Artemisia Extracts by High-Speed Countercurrent Chromatography. Food Chemistry, 129, 679-683. http://dx.doi.org/10.1016/j.foodchem.2011.05.005
[5]	Adams, J.D., Garcia, C. and Garg, G. (2012) Mugwort (Artemisia vulgaris, Artemisia douglasiana, Artemisia argyi) in the Treatment of Menopause, Premenstrual Syndrome, Dysmenorrhea and Attention Deficit Hyperactivity Disorder. Chinese Medicine, 3, 116-123. http://dx.doi.org/10.4236/cm.2012.33019
[6]	Cai, P. (2001) The Pharmacological Action and Application of Artemisiae argyi. Lishizhen Medicine and Materia Medica Research, 12, 1137-1139.
[7]	Lowy, F.D. (1998) Staphylococcus aureus Infections. New England Journal of Medicine, 339, 520-532. http://dx.doi.org/10.1056/NEJM199808203390806
[8]	Otto, A., van Dijl, J.M., Hecker, M. and Becher, D. (2014) The Staphylococcus aureus Proteome. International Journal of Medical Microbiology, 304, 110-120. http://dx.doi.org/10.1016/j.ijmm.2013.11.007
[9]	Costerton, J.W., Montanaro, L. and Arciola, C.R. (2005) Biofilm in Implant Infections: Its Production and Regulation. The International Journal of Artificial Organs, 28, 1062-1068.
[10]	Del Pozo, J.L. and Patel, R. (2007) The Challenge of Treating Biofilm-Associated Bacterial Infections. Clinical Pharmacology and Therapeutics, 82, 204-209. http://dx.doi.org/10.1038/sj.clpt.6100247
[11]	Archer, N.K., Mazaitis, M.J., Costerton, J.W., Leid, J.G., Powers, M.E. and Shirtliff, M.E. (2011) Staphylococcus aureus Biofilms: Properties, Regulation, and Roles in Human Disease. Virulence, 2, 445-459. http://dx.doi.org/10.4161/viru.2.5.17724
[12]	Yu, D., Zhao, L., Xue, T. and Sun, B. (2012) Staphylococcus aureus Autoinducer-2 Quorum Sensing Decreases Biofilm Formation in an icaR-Dependent Manner. BMC Microbiology, 12, 288. http://dx.doi.org/10.1186/1471-2180-12-288
[13]	Cosgrove, S.E., Carroll, K.C. and Perl, T.M. (2004) Staphylococcus aureus with Reduced Susceptibility to Vancomycin. Clinical Infectious Diseases, 39, 539-545. http://dx.doi.org/10.1086/422458
[14]	Diep, B.A. and Otto, M. (2008) The Role of Virulence Determinants in Community Associated MRSA Pathogenesis. Trends in Microbiology, 16, 361-369. http://dx.doi.org/10.1016/j.tim.2008.05.002
[15]	Hiramatsu, K. (2001) Vancomycin-Resistant Staphylococcus aureus: A New Model of Antibiotic Resistance. The Lancet Infectious Diseases, 1, 147-155. http://dx.doi.org/10.1016/S1473-3099(01)00091-3